Novo-Nordisk A/S (NVO) Earnings Date & Reports

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

NVO is expected to report earnings to fall 85.90% to 89 cents per share on May 07

Novo-Nordisk A/S NVO Stock Earnings Reports

Q1'25

Est.

$0.89

Q4'24

Beat

by $5.46

Q3'24

Beat

by $5.24

Q2'24

Beat

by $9.46

Q1'24

Beat

by $4.93

The last earnings report on February 05 showed earnings per share of $6.34, beating the estimate of 87 cents. With 10.92M shares outstanding, the current market capitalization sits at 279.46B.

View a ticker or compare two or three

Compare

Day Trader: Search for Dip TA&FA ($1500)Day Trader: Search for Dip TA&FA ($1500)

Annualized Return+9%

VIEW DETAILS VIEW DETAILS

SUBSCRIBE SUBSCRIBE

NVO